NCAPG2 and glioma: It has been established that NCAPG2 overexpression could potentially alter the signaling pathways, like STAT3 and NF-κB, or other oncogenes to promote proliferation and invasion of the malignancy cells in various cancers including liver cancer, melanoma, lung cancer and glioma (12, 15–17).